Print this page
• Back to Web version of article
Index of Articles From AIDSinfo
Drug Fact Sheets
- An Overview of Aldesleukin (IL-2, Proleukin) (June 7, 2009)
- An Overview of Aptivus (Tipranavir) (September 13, 2012)
- An Overview of Atripla (Efavirenz/Tenofovir/FTC) (April 18, 2013)
- An Overview of Azithromycin (Zithromax) (October 8, 2012)
- An Overview of BMS-663068 (October 22, 2012)
- An Overview of Cenicriviroc (October 22, 2012)
- An Overview of Clarithromycin (Biaxin) (October 5, 2012)
- An Overview of Clindamycin (October 5, 2012)
- An Overview of Cobicistat (GS-9350) (October 25, 2010)
- An Overview of Combivir (AZT/3TC) (September 13, 2012)
- An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) (August 17, 2011)
- An Overview of Dolutegravir (October 11, 2012)
- An Overview of Doxorubicin Hydrochloride (Doxil) (June 8, 2009)
- An Overview of Dronabinol (Marinol) (June 30, 2009)
- An Overview of Edurant (Rilpivirine) (December 11, 2012)
- An Overview of Elvitegravir (October 31, 2012)
- An Overview of Elvucitabine (October 31, 2012)
- An Overview of Emtricitabine (FTC, Emtriva) (September 21, 2012)
- An Overview of Epivir (3TC, Lamivudine) (September 13, 2012)
- An Overview of Epoetin Alfa (Epogen, Procrit) (March 22, 2007)
- An Overview of Epzicom (Abacavir/3TC, Kivexa) (September 13, 2012)
- An Overview of Fluconazole (Diflucan) (November 21, 2012)
- An Overview of Fuzeon (Enfuvirtide, T-20) (September 13, 2012)
- An Overview of Ganciclovir (Cytovene, Vitrasert) (November 14, 2012)
- An Overview of GS-7340 (October 24, 2012)
- An Overview of Ibalizumab (October 22, 2012)
- An Overview of Indinavir (IDV, Crixivan) (September 13, 2012)
- An Overview of Intelence (TMC125, Etravirine) (September 13, 2012)
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (March 13, 2007)
- An Overview of Isentress (Raltegravir, MK-0518) (April 22, 2012)
- An Overview of Isoniazid (INH, Nydrazid) (April 30, 2007)
- An Overview of Kaletra (Lopinavir/Ritonavir) (September 13, 2012)
- An Overview of Lersivirine (October 11, 2012)
- An Overview of Lexiva (Fosamprenavir, Telzir) (September 13, 2012)
- An Overview of Norvir (Ritonavir) (September 14, 2012)
- An Overview of PA-457 (November 23, 2008)
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (October 4, 2012)
- An Overview of Poly-L-Lactic Acid (Sculptra, New-Fill) (January 23, 2007)
- An Overview of Prezista (Darunavir, TMC114) (March 5, 2013)
- An Overview of PRO-140 (October 22, 2012)
- An Overview of Racivir (November 2, 2012)
- An Overview of Rescriptor (Delavirdine) (September 13, 2012)
- An Overview of Reyataz (Atazanavir) (September 13, 2012)
- An Overview of Ribavirin (Copegus, Rebetol, Virazole) (February 12, 2007)
- An Overview of Rifabutin (Mycobutin) (October 3, 2012)
- An Overview of Rifampin (Rifadin, Rimactane) (October 2, 2012)
- An Overview of Saquinavir mesylate (Invirase) (September 13, 2012)
- An Overview of Selzentry (Maraviroc, Celsentri) (September 13, 2012)
- An Overview of S/GSK1265744 (October 11, 2012)
- An Overview of Stavudine (d4T, Zerit) (June 8, 2012)
- An Overview of Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir) (November 30, 2012)
- An Overview of Sulfamethoxazole-Trimethaprim (Bactrim, Septra, Sulfatrim) (June 18, 2007)
- An Overview of Sustiva (Efavirenz, Stocrin) (September 13, 2012)
- An Overview of Tenofovir (TDF, Viread) (September 21, 2012)
- An Overview of Tesamorelin (November 11, 2010)
- An Overview of Trizivir (AZT/3TC/Abacavir) (September 13, 2012)
- An Overview of Truvada (Tenofovir/FTC) (September 13, 2012)
- An Overview of Valproic Acid (December 11, 2007)
- An Overview of Videx (Didanosine, ddI) (September 13, 2012)
- An Overview of Viracept (Nelfinavir) (September 13, 2012)
- An Overview of Viramune (Nevirapine) (November 15, 2012)
- An Overview of Ziagen (Abacavir) (September 14, 2012)
- An Overview of Zidovudine (AZT, Retrovir) (September 13, 2012)
Articles
- FDA Updates Efavirenz Labeling With Expanded Pediatric Indication Information (May 7, 2013)
- Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Released (May 7, 2013)
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (PDF) (May 7, 2013)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Seeks Nominations for the Non-Governmental Co-Chair of the Panel (April 19, 2013)
- What's New in the Pediatric Guidelines? (April 3, 2013)
- Today Is National Native HIV/AIDS Awareness Day (March 20, 2013)
- HHS Perinatal Guidelines Panel Accepting Nominations for New Members (February 22, 2013)
- What's New in the U.S. DHHS Antiretroviral Therapy Guidelines for Adults and Adolescents (February 12, 2013)
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (February 12, 2013)
To read the PDF, click here.
This document will open on the "What's New in the Guidelines?" page; use the table of contents you'll see on the left to navigate through the guidelines.
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (PDF) (November 1, 2012)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Announces New Members (December 21, 2012)
- HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Accepting Nominations for New Members (September 14, 2012)
- NIH/IAS HIV Funding Opportunity Announced (August 17, 2012)
- CDC to Present Live Webcast on High-Impact HIV Prevention (August 17, 2012)
- HIV and Its Treatment (August 2012)
Health information for patients.
To read PDF, click here.
- What's New in the Updated HHS Perinatal Antiretroviral Treatment Guidelines (July 31, 2012)
- Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (July 31, 2012)
To read the PDF, click here.
- AIDS Memorial Quilt in the White House (July 24, 2012)
- NIAID Issues New Clinical Trials Units Funding Opportunity Announcement (April 20, 2012)
- Corrections to Adult and Adolescent ARV Treatment Guidelines (March 29, 2012)
- Join AIDSinfo in Observing National Native HIV/AIDS Awareness Day (March 16, 2012)
- HIV and Pregnancy (February 2012)
Health information for patients.
To read PDF, click here.
- HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected With HIV Receiving Antiretroviral Therapy (December 20, 2011)
Short-course (3-month) therapy with weekly isoniazid-rifapentine is NOT RECOMMENDED for HIV-infected patients receiving antiretroviral therapy.
- Nominations for New Community Members of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines (December 5, 2011)
- Glossary of HIV/AIDS-Related Terms (PDF) (October 2011)
- Call for Nominations for New Scientific/Clinical Members for the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (September 9, 2011)
- Updated HHS "Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced From Disaster Areas" Now Available (August 26, 2011)
- Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced From Disaster Areas (PDF) (August 26, 2011)
- "Drugs That Fight HIV" Poster Features Images of Antiretroviral Medications (August 26, 2011)
- DHHS Adult and Adolescent Antiretroviral Treatment Guidelines Panel Releases Supplemental Information Regarding the Role of Rilpivirine as Initial Therapy (August 16, 2011)
To read PDF, click here.
- What's New in the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (January 10, 2011)
- HHS Perinatal Guidelines Panel Accepting Nominations for New Members (November 5, 2010)
- Antiretroviral Formulations (July 2009)
To read PDF, click here.
- What Do I Need to Know About Immunizations? (June 2009)
To read PDF, click here.
- Recommended Immunizations for HIV-Positive Adults (June 2009)
To read PDF, click here.
- DHHS Adults and Adolescents Antiretroviral Treatment Guidelines Panel's Communication Regarding Abacavir (April 4, 2008)
To read PDF, click here.
- Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients (April 30, 2007)
Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents -- October 10, 2006
To read PDF, click here.
- Update on the New York City "Superbug" (August 11, 2006)
- Preventive HIV Vaccines (May 2006)
To read PDF, click here.
- Therapeutic HIV Vaccines (May 2006)
To read PDF, click here.
- Hepatotoxicity (October 2005)
To read PDF, click here.
- Hyperglycemia (October 2005)
To read PDF, click here.
- Hyperlipidemia (October 2005)
To read PDF, click here.
- Lactic Acidosis (October 2005)
To read PDF, click here.
- Lipodystrophy (October 2005)
To read PDF, click here.
- Osteonecrosis, Osteopenia and Osteoporosis (October 2005)
To read PDF, click here.
- Skin Rash (October 2005)
To read PDF, click here.
- What Is an HIV/AIDS Clinical Trial? (September 2005)
To read PDF, click here.
- The HIV Life Cycle (May 2005)
To read PDF, click here.
- FDA Approves Generic Formulation of Didanosine (ddI) Delayed Release Capsules (December 3, 2004)
- Suggestions for Taking the Liquid Formulation of Ritonavir (August 21, 1998)
- HIV Protease Inhibitors & You (December 1997)
- Developing Options for Perinatal HIV Prevention in the Developing World (June 1997)
- Understanding Viral Load (March 1997)
- Caring for Someone With AIDS at Home: A Guide
Hojas en Español
Articulos en Español
You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art12774.html
General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.